{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:23:54Z","timestamp":1774437834504,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:00:00Z","timestamp":1180051200000},"content-version":"vor","delay-in-days":601,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p> <jats:italic>Polycystic kidney disease, an inherited systemic disorder, is characterized by the development of multiple cysts in the kidneys and other organs. Patients can present at any age, but more often come to clinical attention (unless there is a family history) after age 30. Patients who are diagnosed before age 30 have a worse renal survival. Although palpation of the abdomen occasionally provides a clue to the presence of polycystic kidney disease, radiographic procedures most often suggest the diagnosis. Mutations in the<\/jats:italic> PKD1 <jats:italic>or<\/jats:italic> PKD2 <jats:italic>genes give rise to cyst formation. Flank pain, hematuria, polyuria, nephrolithiasis, urinary tract infections, and hypertension may be part of the syndrome of polycystic kidney disease. It is the fourth most common cause of end\u2010stage renal disease. Blood pressure treatment goals are less than 130\/80 mm Hg. Treatment should include the use of angiotensinconverting enzyme inhibitors.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1524-6175.2005.04137.x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:07:39Z","timestamp":1180094859000},"page":"617-625","source":"Crossref","is-referenced-by-count":6,"title":["Polycystic Kidney Disease"],"prefix":"10.1111","volume":"7","author":[{"given":"Pamela J.","family":"Fall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Michael","family":"Prisant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,25]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022161"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70298-8"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V8101560"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03495-3"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307293290508"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000028643.17901.42"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.413"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92026-5"},{"key":"e_1_2_2_10_2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal\u2010dominant polycystic kidney disease: early occurrence and unique aspects","volume":"12","author":"Ecder T","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.330"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00185.x"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010183231602"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.297"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199003000-00010"},{"key":"e_1_2_2_16_2","volume-title":"USRDS 2004 Annual Data Report: Atlas of End\u2010Stage Renal Disease in the United States","author":"U.S. Renal Data System","year":"2004"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188846"},{"key":"e_1_2_2_18_2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group","volume":"5","author":"Klahr S","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000018407.60002.B9"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00077.x"},{"key":"e_1_2_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2005.04137.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2005.04137.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:04:23Z","timestamp":1694419463000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2005.04137.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1524-6175.2005.04137.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2005.04137.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}